Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Current Assets: 2019-2024

Historic Current Assets for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to $562.5 million.

  • CureVac N.V's Current Assets rose 75.39% to $475.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $475.2 million, marking a year-over-year increase of 75.39%. This contributed to the annual value of $562.5 million for FY2024, which is 9.29% up from last year.
  • Per CureVac N.V's latest filing, its Current Assets stood at $562.5 million for FY2024, which was up 9.29% from $514.7 million recorded in FY2023.
  • Over the past 5 years, CureVac N.V's Current Assets peaked at $1.7 billion during FY2020, and registered a low of $514.7 million during FY2023.
  • Moreover, its 3-year median value for Current Assets was $562.5 million (2024), whereas its average is $557.7 million.
  • In the last 5 years, CureVac N.V's Current Assets spiked by 2,518.43% in 2020 and then tumbled by 44.59% in 2022.
  • Over the past 5 years, CureVac N.V's Current Assets (Yearly) stood at $1.7 billion in 2020, then crashed by 35.11% to $1.1 billion in 2021, then tumbled by 44.59% to $595.9 million in 2022, then declined by 13.62% to $514.7 million in 2023, then grew by 9.29% to $562.5 million in 2024.